The world's leading medical & scientific conference on metabolic health & therapy! Learn more about Metabolic Health Initiative & listen to our podcast👇
Could the amount of sugar we're exposed to before birth and during early childhood influence our Alzheimer's risk decades later?
A fascinating natural experiment from Britain's postwar sugar rationing suggests it might.
In this clip from The Metabolic Link, neurologist and bestselling author @davidperlmutter joins Victoria Field to discuss research linking lower sugar exposure during the first 1,000 days of life with a significantly reduced risk of Alzheimer's disease decades later.
What might this mean for how we think about metabolic health, brain development, and Alzheimer's prevention?
In the full conversation, we explore the emerging science of immunometabolism, how the brain's immune cells contribute to neurodegeneration, and the lifestyle factors that may help protect cognitive health as we age.
Watch the full episode: youtube.com/watch?v=T8eBFnvh…
Ask @DominicDAgosti2 anything. Live, free, tomorrow.
On Tuesday, November 17 at 9am PT / 12pm ET, Dom is going live on Zoom for a full hour of your questions.
Ketogenic diets, metabolic health, ketone supplements, supplements in general, the latest research. Nothing is off the table.
It's completely free and open to everyone.
Register here: live.metabolicinitiative.com…
Could a ketogenic diet paired with low-dose ketamine help prevent relapse in anorexia nervosa?
Anorexia nervosa has one of the highest mortality rates of any psychiatric condition, relapse is common, and there are still no FDA-approved medications to treat it.
A new study tested this combination in activity-based anorexia, a mouse model that mimics food restriction, excessive exercise, and severe weight loss. The animals went through two episodes, separated by a recovery period, to see who relapsed.
A ketogenic diet on its own protected against severe relapse, but only while the animals stayed on it. Once the diet stopped, relapse looked the same as in animals that never got it. Adding a low, sub-anesthetic dose of ketamine during the first episode changed that: the protection held for more than 10 days, even after the diet was stopped.
Electron microscopy offered a clue as to why. The ketogenic diet lengthened inhibitory GABAergic synapses in the hippocampus, a possible mechanism behind the lower relapse vulnerability.
This does not mean ketamine or a ketogenic diet is a treatment for anorexia in people, and it is early-stage rodent research. But it does point to a new, mechanism-based strategy that researchers can now explore in clinical studies.
Get our free Ketogenic Metabolic Therapy ebook, with a breakdown of this paper and many more: membership.metabolicinitiati…
Could ketogenic therapy help some people with drug-resistant epilepsy take fewer seizure medications?
For many people with drug-resistant epilepsy, the burden isn't only the seizures. It's managing multiple anti-seizure medications and their side effects.
A clinical cohort study followed 56 participants with drug-resistant epilepsy, 34 children and 22 adults, who stayed on ketogenic diet therapy for at least six months.
The results: 64.3% were able to reduce or withdraw at least one anti-seizure medication. Among adults, average anti-seizure medication load dropped by about 24.5%.
Importantly, these changes happened inside a supervised ketogenic diet therapy program. Anti-seizure medications should never be reduced or stopped without guidance from your medical team.
This does not mean ketogenic therapy replaces medication for everyone. But it does support an important clinical idea: for some patients, changing brain metabolism may help lower medication burden as part of a medically supervised treatment plan.
Get our free Ketogenic Metabolic Therapy ebook, with a breakdown of this paper and many more: membership.metabolicinitiati…
Who is most likely to benefit from ketogenic therapy for drug-resistant epilepsy? A clinical study points to a clue in the genes.
Ketogenic diets have been used for drug-resistant epilepsy for decades. But one major question remains: who is most likely to benefit?
A clinical study looked at ketogenic diet response in people with drug-resistant epilepsy and compared outcomes based on whether patients had a known genetic cause for their seizures.
The study found that ketogenic diet effectiveness appeared to be stronger in patients whose epilepsy was linked to a causative genetic mutation compared with those without a clear genetic diagnosis.
This does not mean every genetic epilepsy will respond to a ketogenic diet, and it does not mean ketogenic therapy should automatically replace medication. But it does point toward a more personalized future, where genetics may help clinicians decide when metabolic therapy should be considered earlier in the treatment plan.
Get our free research guide, with a breakdown of this paper and many more: membership.metabolicinitiati…
Is your creatine gummy actually giving you creatine?
In this clip from The Metabolic Link, @DominicDAgosti2 asks Dr. Jordan Glenn, Head of Science at @joinsuppco, what the failures in SuppCo's creatine testing report actually looked like: four of six gummies failed identity and potency testing, while all five powders passed. Dr. Glenn explains why the problem is rarely a harmful product and far more often one that skips the active ingredient.
In the full episode of The Metabolic Link, they also explore:
• How some brands can pass Amazon's one-time "golden sample" test, then sell something different
• Why the FDA rarely tests a supplement before it reaches the shelf
• How much citrulline a pre-workout needs to raise nitric oxide, and why most labels fall short
• Why most people now take creatine for brain health, and what the evidence supports
• How to audit the supplements already in your cabinet
Watch the full episode: youtube.com/watch?v=tveB6U-l…
Could ketones help protect the brain, heart, and other organs after a stroke, heart attack, or other ischemic injuries?
A systematic review examined decades of mostly preclinical research on ketogenic diets, ketone bodies, and ischemic injury across organs, including the brain, heart, liver, kidneys, gut, and eyes.
The review found that ketogenic interventions and the ketone body beta-hydroxybutyrate were often associated with protective effects in experimental models, including reduced oxidative stress, inflammation, mitochondrial dysfunction, and cell death pathways.
An important nuance: the potential benefits appeared tied to a true ketogenic metabolic state or ketone-based intervention, not simply eating a high-fat, high-calorie diet.
This does not mean a ketogenic diet should be used as an emergency treatment for stroke or heart attack, and it does not prove the same effects in humans. But it does point to a fascinating therapeutic pathway: using metabolism to influence tissue resilience during ischemic stress.
Get our free Ketogenic Metabolic Therapy ebook, with a breakdown of this paper and many more: membership.metabolicinitiati…
A recent study reframes how we think about intellectual disabilities, starting with how the brain is fueled.
Neurons rely on astrocytes to convert glucose into lactate to keep synapses firing. Researchers studied SNX27, a genetic mutation known to cause intellectual disabilities in humans, by replicating it in mice. The mutation disrupted astrocyte metabolism, starving neurons of lactate, and the mice developed cognitive and learning deficits.
Bypassing the broken pathway with a ketogenic diet or lactate supplementation completely reversed those deficits.
Intellectual disabilities have traditionally been seen as broken wiring that is hard to fix. This study suggests at least some cognitive issues may be metabolic, closer to a dead battery than broken wiring, and that alternate fuels can restore brain function.
Get our free Ketogenic Metabolic Therapy ebook, CliffsNotes-style highlights of more than 150 synthesized peer-reviewed papers on metabolic health and therapy: membership.metabolicinitiati…
A retrospective study at the Cleveland Clinic looked at whether a targeted ketogenic protocol could move the needle on fertility in PCOS.
Polycystic ovary syndrome, now also known as polyendocrine metabolic ovarian syndrome or PMOS, affects up to 20% of reproductive age individuals and is a leading cause of infertility. Researchers analyzed patients with PMOS who followed the protocol for at least three months. The reported results: 100% of the women restored regular, healthy menstrual cycles, and of those who wanted to get pregnant, over 55% achieved it, with a 100% success rate in the subset not taking metformin.
A key piece of nuance: weight loss was similar between groups, suggesting pregnancy success was not driven purely by weight loss, but also by the metabolic state of ketosis and improvements in insulin sensitivity.
Get our free Ketogenic Metabolic Therapy ebook covering the latest science on metabolic health and therapy, including this study: membership.metabolicinitiati…
What actually changed in the new Dietary Guidelines?
In this clip from The Metabolic Link, @victoria_field_ asks Dr. Maya Maroto, Executive Director of @metcoalition, whether the new language on lower-carbohydrate diets for people with certain chronic diseases is the landmark it appears to be. Dr. Maroto explains why the Coalition sees it as a first, and how it puts that language to work with Congress and the administration.
The Coalition for Metabolic Health is a national network of clinicians, researchers, policy experts, and advocates working to advance high-quality nutrition science and drive change across policy and clinical practice.
In the full episode of The Metabolic Link, they also explore:
• Why guideline changes can take years to reach school lunches and hospital menus
• How congressional report language turns into NIH research funding
• Why the Coalition keeps metabolic health bipartisan and accepts no food or supplement industry funding
• Why many dietitians remain cautious about ketogenic diets
• Whether carbohydrate restriction is affordable on a SNAP budget
Watch the full episode: youtu.be/CUMABHvbbTc
It's tomorrow. Last chance to save your spot.
This Wednesday, October 14, @AnnetteBosworth goes live for a free, one-hour Q&A, moderated by @DominicDAgosti2 and @victoria_field_.
Swipe to see a few of the questions registrants are already asking, from autophagy on a sardine fast to protein, menopause, and GLP-1 medications.
What would you ask Dr. Boz? Register today, submit your question, and join the conversation live.
📅 Tomorrow, Wednesday, October 14
🕘 9 AM PT / 12 PM ET
💻 Free on Zoom · 60 minutes · No membership required
Can't make it live? Register anyway, and we'll email you details on how to watch the recording.
Register at live.metabolicinitiative.com.
What would you ask @AnnetteBosworth?
Join us next Wednesday, October 14, for a free, one-hour Live Q&A with @AnnetteBosworth, moderated by @DominicDAgosti2 and Victoria Field.
Nearly 90 questions have already been submitted, covering ketogenic metabolic therapy, glucose and ketone patterns, fasting, GLP-1 medications, and the real-world challenges of putting these strategies into practice.
Now it's your turn! Register, submit your question, and join the conversation live.
📅 Wednesday, October 14
🕘 9 AM PT / 12 PM ET
💻 Free on Zoom · 60 minutes · No membership required
Can't make it live? Register anyway, and we'll email you details on how to watch the recording.
Register at live.metabolicinitiative.com.
Have questions about GLP-1s and ketosis?
In this clip from The Metabolic Link, @AnnetteBosworth shares her clinical observations from patients who were already in ketosis when they started a GLP-1 at a low dose, and @DominicDAgosti2 discusses how being in ketosis could potentially influence the metabolic response.
Now it’s your turn. For one hour, Dr. Boz will take your questions live on Zoom, with Dom and Victoria Field moderating.
Bring the questions that matter to you. A few to get you thinking:
• How does ketogenic nutrition fit alongside GLP-1s, and what should be considered when reducing or discontinuing them?
• Why is my morning glucose still high, or my ketones low, despite eating very few carbs?
• How do I know when fasting is helping versus when I’m pushing it too far?
• In perimenopause or menopause, if cutting carbs isn’t working like it used to, what should I reassess?
Wednesday, October 14 · 9 AM PT / 12 PM ET
Free · Live on Zoom · 60 minutes · No membership required
Can’t make it live? Register anyway, and we’ll email you details on how to watch the recording.
Register at live.metabolicinitiative.com.
What would an emergency physician tell his patients if he could have met them 20 years before their crisis?
Dr. Michael Doney, MD, MPH, MS, spent years as a board-certified emergency physician managing the acute consequences of chronic disease. Today he is Executive Medical Director of @biograph, a preventive health clinic that combines whole-body MRI, cardiovascular imaging, DEXA, VO2 max testing, movement analysis, blood work, and genetics with a team of physicians, registered dietitians, exercise physiologists, and sleep specialists.
In this episode he walks @DominicDAgosti2 through how that data turns into a plan: why a high relative VO2 max can mask low skeletal muscle mass, especially in women in their late 40s and 50s; why Biograph talks about body recomposition, fiber, protein, and carbohydrate quality instead of weight loss alone; and what an internal study of about 1,000 members suggested about fatty liver disease in women, who in that cohort showed MASLD at lower BMI and visceral fat levels than men, with higher insulin resistance and fewer liver enzyme abnormalities. He also takes on the main critique of whole-body MRI, explaining how a standardized reporting system, subspecialty radiologists, and clinical context brought Biograph's reported referral rate for follow-up testing to about 5.4%, compared with the roughly one-third figure often cited.
The conversation also covers AI in imaging and in personal health data, diffusion-weighted MRI, a new study with Vero Bioscience tracking proteomic organ age through lifestyle interventions, mental health screening, how Biograph supports members already on GLP-1 medications, and what it would take to make this kind of prevention broadly accessible.
Viewers will come away with a clearer picture of what a comprehensive preventive assessment measures, where its limits are, and how the results translate into nutrition, exercise, and sleep interventions.
What would you ask Dr. Boz?
@AnnetteBosworth and @DominicDAgosti2 just finished recording a new episode of The Metabolic Link, and now it’s your turn to ask the questions.
For one hour, Dr. Boz will answer your questions live on Zoom, with Dom and Victoria Field moderating.
A few to get you thinking:
• Why is my morning glucose still high, or my ketones low, even when I’m eating very few carbs?
• How do I know when fasting is helping versus when I may be pushing it too far?
• How does ketogenic nutrition fit alongside GLP-1s, and what should people consider when reducing or coming off these medications?
• In perimenopause or menopause, what should I reassess if cutting carbs doesn’t seem to be working like it used to?
Wednesday, October 14 · 9 AM PT / 12 PM ET
Free · Live on Zoom · 60 minutes · No membership required
Can’t make it live? Register anyway, and we’ll email you details on how to watch the recording.
Register at live.metabolicinitiative.com.